Seek Returns logo

CVS vs. DXCM: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at CVS and DXCM, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolCVSDXCM
Company NameCVS Health CorporationDexCom, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Providers & ServicesHealth Care Equipment & Supplies
Market Capitalization98.28 billion USD26.29 billion USD
ExchangeNYSENasdaqGS
Listing DateFebruary 21, 1973April 14, 2005
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of CVS and DXCM by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CVS vs. DXCM: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolCVSDXCM
5-Day Price Return2.54%0.89%
13-Week Price Return14.92%-19.15%
26-Week Price Return14.38%-1.82%
52-Week Price Return24.50%-0.07%
Month-to-Date Return2.79%-0.36%
Year-to-Date Return72.62%-13.78%
10-Day Avg. Volume6.88M6.50M
3-Month Avg. Volume7.51M4.32M
3-Month Volatility26.09%41.38%
Beta0.481.53

Profitability

Return on Equity (TTM)

CVS

5.95%

Health Care Providers & Services Industry

Max
24.86%
Q3
15.79%
Median
8.56%
Q1
5.75%
Min
-1.64%

CVS’s Return on Equity of 5.95% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

DXCM

25.62%

Health Care Equipment & Supplies Industry

Max
29.93%
Q3
16.99%
Median
9.28%
Q1
5.10%
Min
-12.52%

In the upper quartile for the Health Care Equipment & Supplies industry, DXCM’s Return on Equity of 25.62% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

CVS vs. DXCM: A comparison of their Return on Equity (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Net Profit Margin (TTM)

CVS

1.17%

Health Care Providers & Services Industry

Max
11.56%
Q3
5.45%
Median
2.83%
Q1
1.13%
Min
-1.71%

CVS’s Net Profit Margin of 1.17% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

DXCM

13.29%

Health Care Equipment & Supplies Industry

Max
24.41%
Q3
13.71%
Median
10.08%
Q1
5.96%
Min
-5.58%

DXCM’s Net Profit Margin of 13.29% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.

CVS vs. DXCM: A comparison of their Net Profit Margin (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Operating Profit Margin (TTM)

CVS

2.44%

Health Care Providers & Services Industry

Max
19.08%
Q3
9.66%
Median
4.77%
Q1
2.46%
Min
-0.83%

CVS’s Operating Profit Margin of 2.44% is in the lower quartile for the Health Care Providers & Services industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

DXCM

15.98%

Health Care Equipment & Supplies Industry

Max
31.09%
Q3
18.11%
Median
15.07%
Q1
8.48%
Min
-0.28%

DXCM’s Operating Profit Margin of 15.98% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

CVS vs. DXCM: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Profitability at a Glance

SymbolCVSDXCM
Return on Equity (TTM)5.95%25.62%
Return on Assets (TTM)1.78%8.49%
Net Profit Margin (TTM)1.17%13.29%
Operating Profit Margin (TTM)2.44%15.98%
Gross Profit Margin (TTM)13.82%60.01%

Financial Strength

Current Ratio (MRQ)

CVS

0.80

Health Care Providers & Services Industry

Max
2.00
Q3
1.51
Median
1.29
Q1
0.92
Min
0.14

CVS’s Current Ratio of 0.80 falls into the lower quartile for the Health Care Providers & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

DXCM

1.52

Health Care Equipment & Supplies Industry

Max
5.19
Q3
3.00
Median
2.13
Q1
1.44
Min
0.86

DXCM’s Current Ratio of 1.52 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.

CVS vs. DXCM: A comparison of their Current Ratio (MRQ) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Debt-to-Equity Ratio (MRQ)

CVS

0.86

Health Care Providers & Services Industry

Max
2.29
Q3
1.24
Median
0.74
Q1
0.50
Min
0.00

CVS’s Debt-to-Equity Ratio of 0.86 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

DXCM

0.97

Health Care Equipment & Supplies Industry

Max
1.61
Q3
0.76
Median
0.45
Q1
0.14
Min
0.00

DXCM’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.97. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

CVS vs. DXCM: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Interest Coverage Ratio (TTM)

CVS

3.08

Health Care Providers & Services Industry

Max
14.47
Q3
7.50
Median
4.52
Q1
2.12
Min
-4.44

CVS’s Interest Coverage Ratio of 3.08 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.

DXCM

978.00

Health Care Equipment & Supplies Industry

Max
56.35
Q3
25.56
Median
9.60
Q1
3.78
Min
-26.49

With an Interest Coverage Ratio of 978.00, DXCM demonstrates a superior capacity to service its debt, placing it well above the typical range for the Health Care Equipment & Supplies industry. This stems from either robust earnings or a conservative debt load.

CVS vs. DXCM: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Financial Strength at a Glance

SymbolCVSDXCM
Current Ratio (MRQ)0.801.52
Quick Ratio (MRQ)0.621.32
Debt-to-Equity Ratio (MRQ)0.860.97
Interest Coverage Ratio (TTM)3.08978.00

Growth

Revenue Growth

CVS vs. DXCM: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CVS vs. DXCM: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CVS

3.40%

Health Care Providers & Services Industry

Max
5.93%
Q3
2.59%
Median
1.35%
Q1
0.00%
Min
0.00%

With a Dividend Yield of 3.40%, CVS offers a more attractive income stream than most of its peers in the Health Care Providers & Services industry, signaling a strong commitment to shareholder returns.

DXCM

0.00%

Health Care Equipment & Supplies Industry

Max
4.15%
Q3
1.76%
Median
0.79%
Q1
0.00%
Min
0.00%

DXCM currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

CVS vs. DXCM: A comparison of their Dividend Yield (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend Payout Ratio (TTM)

CVS

74.62%

Health Care Providers & Services Industry

Max
185.33%
Q3
74.82%
Median
36.00%
Q1
0.00%
Min
0.00%

CVS’s Dividend Payout Ratio of 74.62% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

DXCM

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
66.60%
Median
27.49%
Q1
0.00%
Min
0.00%

DXCM has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

CVS vs. DXCM: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend at a Glance

SymbolCVSDXCM
Dividend Yield (TTM)3.40%0.00%
Dividend Payout Ratio (TTM)74.62%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

CVS

21.93

Health Care Providers & Services Industry

Max
40.02
Q3
29.75
Median
21.09
Q1
14.18
Min
7.05

CVS’s P/E Ratio of 21.93 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

DXCM

45.59

Health Care Equipment & Supplies Industry

Max
67.29
Q3
47.01
Median
30.94
Q1
23.91
Min
10.79

DXCM’s P/E Ratio of 45.59 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

CVS vs. DXCM: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Sales Ratio (TTM)

CVS

0.26

Health Care Providers & Services Industry

Max
3.15
Q3
1.87
Median
0.74
Q1
0.27
Min
0.09

In the lower quartile for the Health Care Providers & Services industry, CVS’s P/S Ratio of 0.26 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

DXCM

6.06

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.86
Q1
2.07
Min
0.74

DXCM’s P/S Ratio of 6.06 is in the upper echelon for the Health Care Equipment & Supplies industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

CVS vs. DXCM: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Book Ratio (MRQ)

CVS

1.13

Health Care Providers & Services Industry

Max
7.33
Q3
4.45
Median
2.52
Q1
1.15
Min
0.66

CVS’s P/B Ratio of 1.13 is in the lower quartile for the Health Care Providers & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

DXCM

13.30

Health Care Equipment & Supplies Industry

Max
10.85
Q3
6.56
Median
3.53
Q1
2.36
Min
0.71

At 13.30, DXCM’s P/B Ratio is at an extreme premium to the Health Care Equipment & Supplies industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

CVS vs. DXCM: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Providers & Services and Health Care Equipment & Supplies industry benchmarks.

Valuation at a Glance

SymbolCVSDXCM
Price-to-Earnings Ratio (TTM)21.9345.59
Price-to-Sales Ratio (TTM)0.266.06
Price-to-Book Ratio (MRQ)1.1313.30
Price-to-Free Cash Flow Ratio (TTM)16.0445.65